Rainscreen Wall Cladding Fastest-Growing Product in the Wall Cladding Sector

The UK wall cladding market has been affected by reduced demand from key end-use sectors since 2017, recording only modest growth of 13% in total installed area between 2015 and 2019.

The Covid-19 pandemic has had a profound effect on the market with site closures in early spring 2020 leading to project delays and product shortages in some instances as contractors and manufacturers adapted to safer production and working practices.

Looking to a positive, rainscreen cladding has benefitted from increased retrofitting on offices and apartment blocks as the need to protect structures from extreme weather and water ingress has increased.

Jane Tarver, editor of the Wall Cladding Market Report at AMA Research states “Rainscreen cladding systems have been a fast-growing product sector in recent years, estimated to have quadrupled in terms of area installed from 2013 levels. The main area of application has been offices, although there has also been strong demand for use on residential towers, demand further boosted by the requirement to replace unsafe ACM cladding on a number of high-rise residential buildings in the wake of the Hackitt Review into the Grenfell Tower disaster. As a result of the ban on use of ACM cladding with a polyethylene core on high rise residential developments, the market share of these types of products and systems will be impacted while others will gain market share from changes in product specification”.

Grenfell and the Hackitt review continues to influence the market. With a ban on the use of ACM cladding this has led to an increased demand for products with the highest level of fire safety classifications such as stone, glass wool, concrete and fibre cement.

Following decline of around 13% for installed cladding area (million m2) in 2020, the market is forecast to return to growth in 2021 thereafter seeing annual increases of around 4-5% to reach around 48 million m2 by 2024.

Source: https://www.amaresearch.co.uk/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.